Sanofi
Sanofi CFO set to step down this year
April 18, 2018Medical Communications, Research and Development Sanofi, biotech, cfo, drugs, pharma, pharmaceutical
After a busy start to the year, with a number of acquisitions and a few divestments, Sanofi’s Chief Financial Officer, …
Sanofi looks to trim down with divestments
April 16, 2018Sales and Marketing Charterhouse Capital, Sanofi, Zentiva, biotech, drugs, pharma, pharmaceutical
Sanofi has begun part of a larger process of slimming down its business with the sales of 12 medicines. It …
Sanofi to invest €350m in new Canadian vaccine plant
April 12, 2018Manufacturing and Production Canada, Sanofi, pharma, vaccines
Sanofi has announced plans to spend €350 million on a new vaccine facility located in Toronto, Canada, a move which, …
Top Ten most popular articles on Pharmafile.com this week
April 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Boehringer Ingelheim, Kite, Nordic Nanovector, Pfizer, Roche, Sanofi, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
Some of the biggest news this week concerns companies that are looking to move on parts of their business, but …
NICE rejects Dupixent for atopic dermatitis on cost grounds, Sanofi responds
April 4, 2018Research and Development, Sales and Marketing Dupixent, NICE, Sanofi, atopic dermatitis, eczema, pharma
UK drug watchdog NCIE has issued draft guidance rejecting the routine use of Sanofi’s Dupixent (dupilumab) for the treatment of …
Ablynx’s vobarilizumab trial fails and sees two patient deaths in systemic lupus erythematosus
March 26, 2018Research and Development, Sales and Marketing AbbVie, Ablynx, Sanofi, Vobarilizumab, pharma, systemic lupus erythematosus
Ablynx has revealed that its interleukin 6 pathway via its IL-6 receptor (IL-6R) vobarilizumab failed to meet its primary endpoint …
Sanofi and Regeneron reveal strong data and a price drop for Praluent
March 12, 2018Research and Development, Sales and Marketing Regeneron, Sanofi, pharma, praluent
Sanofi and Regeneron have revealed strong new data for its PCSK9 inhibitor Praluent showing the first-ever reduction in deaths within …
Top Ten most popular articles on Pharmafile.com this week
March 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Biogen, Celgene, EMA, Gilead, HIV, Herceptin, Japan, NHS, Ontruzant, Sanofi, opioid crisis, opioids, pharma, real world data, top ten, zinbryta
After a particularly jarring bout of cold weather and snow, we may just have seen off the worst of winter …
EvoTec to command vast Sanofi resources in infectious disease R&D partnership
March 8, 2018Research and Development, Sales and Marketing Evotec, Sanofi, infectious disease, infective disease, pharma
Sanofi has announced it is to team up with biotech drug discovery specialist EvoTec to leverage a new open innovation …
Sanofi’s controversial dengue vaccine may still hit US market, despite Philippines disaster
March 7, 2018Sales and Marketing FDA, Philippines, Sanofi, US, dengue, dengvaxia, pharma
Sanofi has revealed that the ongoing debacle in the Philippines concerning its dengue vaccine Dengvaxia has not deterred it from …
Former Sanofi exec accused of sexting and indecent exposure demands €1.2m
March 7, 2018Research and Development, Sales and Marketing Sanofi, pharma
A former Sanofi executive fired for sexting, indecent exposure and other alleged sexual harassment charges has been demanding up to …
Sanofi in $155m influenza vaccine deal
February 12, 2018Sales and Marketing SK Chemicals, Sanofi, Sanofi Pasteur, biotech, drugs, pharma, pharmaceutical
Sanofi has revealed that it has agreed a deal with SK Chemicals, a South Korean vaccine manufacturer, to license its …
PTx picks up radiation drug and plant from Sanofi
February 6, 2018Manufacturing and Production, Sales and Marketing Partnership Therapeutics, Sanofi, biotech, drugs, pharma, pharmaceutical
A Boston-based biotech, only a few weeks old, has moved quickly to secure both the drug Leukine and the plant …
Philippines’ launches legal action after Sanofi refuses to refund over dengue vaccine damages
February 5, 2018Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
Sanofi has refused both requests from the Government of the Philippines to refund used doses of its Dengvaxia vaccine as …
Top Ten most popular articles on Pharmafile.com this week
February 2, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Alzheimer's, Apotex, AstraZeneca, Brexit Health Alliance, CDC, Duchenne Muscular Dystrophy, EMA, Italy, Sanofi, amazon, brexit, santhera, top ten
It’s the first Friday of February, and it’s time for another recap of the top ten articles most popular with …
Latest content
Five Facts about cardiovascular disease
